Dr Andrew Lewington BSc (Hons) MEd MD FRCP
Consultant Renal Physician/Honorary Clinical Associate Professor
Director of Undergraduate Medical Education Leeds Teaching Hospitals
Dr Lewington studied renal medicine in Leicester UK and at Washington University USA, where he
investigated the molecular mechanisms underlying acute kidney injury (AKI). He works as a full-time
NHS Consultant Renal Physician and is Director of Undergraduate Medical Education for the Leeds
Teaching Hospitals. Dr Lewington provides a specialist renal opinion for critically ill patients on the
intensive care units across Leeds and recently introduced citrate anticoagulation for continuous venovenous haemodialysis (CVVHD). He was an expert adviser on the National Clinical Enquiry into Patient
Outcomes and Death (NCEPOD) adding insult to injury acute kidney injury report in 2009. He was
appointed to the Department of Health Acute Kidney Injury Delivery Board to address the
recommendations proposed in the NCEPOD report. In 2011 he was appointed Chair of the NICE
accredited Renal Association Clinical Practice Guidelines Committee. He was a member of the NICE
AKI and IV Fluid Therapy Clinical Practice Guideline Committee and the NICE AKI and RRT Quality
Standards Group.In 2014 he was appointed Chair of the NHS England AKI Risk workstream.Dr
Lewington is Chair of the UK Kidney Research Consortium AKI Study Group and his research is focused
on biomarker discovery and development.He is a member of the ISN AKI committee and Co-Chair of the
Education workstream of the ISN 0 by 25 initiative.Despite having no dedicated research timeDr
Lewington is Chief Investigator for the NIHR Kidney transplant biomarker study and an Epidemiology of
AKI in Critically Ill Patients on ICU. He is a co-applicant on a £1.2M grant from from the NIHR for the
Diagnostic Evaluation Cooperative to investigate the clinical and cost effectiveness of biomarkers in the
NHS. He is a co-applicant on a successful MRC Bioinformatics grant. Most recently he has secured
NIHR funding to evaluate ways of preventing AKI in the community and HTA funding to analyse the
economic impact of AKI on the ICU.He has 57 peer-reviewed publications on PubMed.